168 related articles for article (PubMed ID: 37121769)
21. Case of lymphadenopathy with lytic bone lesions.
Kalantri SA; Nath UK; Banerjee D; Bhattacharyya M
BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28320703
[TBL] [Abstract][Full Text] [Related]
22. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features.
Taddesse-Heath L; Meloni-Ehrig A; Scheerle J; Kelly JC; Jaffe ES
Mod Pathol; 2010 Jul; 23(7):991-9. PubMed ID: 20348882
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity in the diagnosis of plasmablastic lymphoma, plasmablastic myeloma, and plasmablastic neoplasm: a scoping review.
Mori H; Fukatsu M; Ohkawara H; Oka Y; Kataoka Y; Taito S; Ikezoe T
Int J Hematol; 2021 Dec; 114(6):639-652. PubMed ID: 34462886
[TBL] [Abstract][Full Text] [Related]
24. Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways.
Witte HM; Künstner A; Hertel N; Bernd HW; Bernard V; Stölting S; Merz H; von Bubnoff N; Busch H; Feller AC; Gebauer N
Blood Adv; 2022 Jan; 6(2):637-651. PubMed ID: 34714908
[TBL] [Abstract][Full Text] [Related]
25. Plasmablastic Lymphoma Presenting as Extensive Peritoneal and Retroperitoneal Nodules in an HIV-Positive Patient.
Pokhrel A; Yuldasheva O; Mirashi E; Nair K; Salyana M; Jaswani V; Avezbakiyev B; Wang JC
J Investig Med High Impact Case Rep; 2022; 10():23247096211065633. PubMed ID: 35073776
[TBL] [Abstract][Full Text] [Related]
26. Primary plasmablastic lymphoma of the gastrointestinal tract: A series of 13 HIV-negative cases and a review of literature.
Fu Z; Wang H; Lauwers GY; Jiang K; Jayaratne NL; Bridglal S; Dong N; Wang E; Chen L; Barclift DP; Zhang L
Ann Diagn Pathol; 2023 Dec; 67():152204. PubMed ID: 37639839
[TBL] [Abstract][Full Text] [Related]
27. Primary central nervous system plasmablastic lymphoma in an HIV-positive patient.
Rhoades R; Gong J; Palmisiano N; Alpdogan O
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30872336
[TBL] [Abstract][Full Text] [Related]
28. [Plasmablastic lymphoma].
Fernández-Álvarez R; Sancho JM; Ribera JM
Med Clin (Barc); 2016 Nov; 147(9):399-404. PubMed ID: 27576534
[TBL] [Abstract][Full Text] [Related]
29. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
Koizumi Y; Uehira T; Ota Y; Ogawa Y; Yajima K; Tanuma J; Yotsumoto M; Hagiwara S; Ikegaya S; Watanabe D; Minamiguchi H; Hodohara K; Murotani K; Mikamo H; Wada H; Ajisawa A; Shirasaka T; Nagai H; Kodama Y; Hishima T; Mochizuki M; Katano H; Okada S
Int J Hematol; 2016 Dec; 104(6):669-681. PubMed ID: 27604616
[TBL] [Abstract][Full Text] [Related]
30. Atypical presentation of plasmablastic lymphoma in immunocompetent patient.
Khan MD; Natarajan S; Lekharaju V
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848405
[TBL] [Abstract][Full Text] [Related]
31. Plasmablastic lymphoma presenting as a large intracardiac mass and bilateral pleural effusions.
Qing X; Enbom E; Qing A; French S; Cai J
Exp Mol Pathol; 2016 Feb; 100(1):79-81. PubMed ID: 26607603
[TBL] [Abstract][Full Text] [Related]
32. Plasmablastic extramedullary plasmacytoma associated with Epstein-Barr virus arising in an immunocompetent patient with multiple myeloma.
Sasaki S; Hashimoto K; Nakatsuka S; Hasegawa M; Nakano T; Nagata S; Kanakura Y; Hayashi N
Intern Med; 2011; 50(21):2615-20. PubMed ID: 22041368
[TBL] [Abstract][Full Text] [Related]
33. Plasmablastic lymphoma in Johannesburg, South Africa, in the era of widescale antiretroviral therapy use.
Vaughan J; Perner Y; Mayne E; Wiggill T
HIV Med; 2021 Mar; 22(3):225-230. PubMed ID: 33022825
[TBL] [Abstract][Full Text] [Related]
34. A challenging diagnosis of plasmablastic lymphoma: importance of integrating morpholgy immunohistochemistry and flow cytometry findings (case report).
Kmira Z; Ahmed G; Wided C; Wided M; Zeineb N; Nihed A; Yosra BY; Regaieg H; Nejia B; Abderrahim K
Pan Afr Med J; 2023; 45():158. PubMed ID: 37869229
[TBL] [Abstract][Full Text] [Related]
35. MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.
Ramis-Zaldivar JE; Gonzalez-Farre B; Nicolae A; Pack S; Clot G; Nadeu F; Mottok A; Horn H; Song JY; Fu K; Wright G; Gascoyne RD; Chan WC; Scott DW; Feldman AL; Valera A; Enjuanes A; Braziel RM; Smeland EB; Staudt LM; Rosenwald A; Rimsza LM; Ott G; Jaffe ES; Salaverria I; Campo E
Haematologica; 2021 Oct; 106(10):2682-2693. PubMed ID: 33951889
[TBL] [Abstract][Full Text] [Related]
36. HIV-related plasmablastic lymphoma causing extensive bone destruction in the mandible.
Kayahara GM; Valente VB; Salzedas LMP; Passador-Santos F; Furuse C; Biasoli ÉR; Miyahara GI; Bernabé DG
Oral Oncol; 2022 Mar; 126():105761. PubMed ID: 35151011
[TBL] [Abstract][Full Text] [Related]
37. [HIV-negative plasmablastic lymphoma sustaining long-term response after autologous peripheral blood stem cell transplantation].
Kitagawa T; Onaka T; Yonezawa A
Rinsho Ketsueki; 2022; 63(3):201-205. PubMed ID: 35387933
[TBL] [Abstract][Full Text] [Related]
38. An unusual case of paediatric plasmablastic lymphoma presenting with malignant effusion and the challenges in its diagnosis.
Modi N; Khurana U; Mukhopadhyay S; Joshi D; Soni D; Chaudhary N; Malik S; Shet T
Diagn Cytopathol; 2021 Oct; 49(10):E389-E394. PubMed ID: 34296830
[TBL] [Abstract][Full Text] [Related]
39. Recurrent and self-healing cutaneous monoclonal plasmablastic infiltrates in a patient with AIDS and Kaposi sarcoma.
Gilaberte M; Gallardo F; Bellosillo B; Saballs P; Barranco C; Serrano S; Pujol RM
Br J Dermatol; 2005 Oct; 153(4):828-32. PubMed ID: 16181470
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous localization of plasmablastic multiple myeloma with heterotopic expression of CD3 and CD4: Skin involvement revealing systemic disease.
Varricchio S; Pagliuca F; Travaglino A; Gallo L; Villa MR; Mascolo M
J Cutan Pathol; 2019 Aug; 46(8):619-622. PubMed ID: 31025408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
